Key result
Influenza vaccination in patients with rheumatoid arthritis induces an adequate humoral response and does not induce clinical exacerbation of the disease.
Why the study?
Does influenza vaccination improve immunogenicity and maintain safety in patients with rheumatoid arthritis?
Population
Patients with rheumatoid arthritis (RA) and otherwise healthy persons
Design
Review
Authors
Loading...
Supports influenza vaccination in RA without exacerbation; leaves open randomized confirmation of immunogenicity and durability.
Does influenza vaccination improve immunogenicity and maintain safety in patients with rheumatoid arthritis?
Influenza vaccination in patients with rheumatoid arthritis is safe, does not exacerbate the disease, and induces an adequate humoral response.
Ori Elkayam (2006) conducted a review in Rheumatoid arthritis. Influenza vaccination was evaluated on Safety and immunogenicity. Influenza vaccination in patients with rheumatoid arthritis induces an adequate humoral response and does not induce clinical exacerbation of the disease.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: